Cargando…

Reactivation of SARS-CoV-2 infection following recovery from COVID-19

INTRODUCTION: Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zhihai, Xie, Wen, Ge, Ziruo, Wang, Yajie, Zhao, Hong, Wang, Jingjing, Xu, Yanli, Zhang, Wei, Song, Meihua, Cui, Shuping, Wang, Xiankun, Pan, Calvin Q.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869688/ https://www.ncbi.nlm.nih.gov/pubmed/33848891 http://dx.doi.org/10.1016/j.jiph.2021.02.002

Ejemplares similares

Clinical features and corresponding immune function status of recurrent viral polymerase chain reaction positivity in patients with COVID-19 : A meta- analysis and systematic review
por: Ren, Xingxiang, et al.
Publicado: (2021)

Difference of Clinical Characteristics in Patients with Omicron and Delta Variants of SARS-CoV-2 in Beijing, China
por: Tian, Di, et al.
Publicado: (2023)

COVID-19 Cases from the First Local Outbreak of the SARS-CoV-2 B.1.1.7 Variant in China May Present More Serious Clinical Features: A Prospective, Comparative Cohort Study
por: Song, Yang, et al.
Publicado: (2021)

Hydroa Vacciniforme-like Lymphoproliferative disorder in an adult invades the liver and bone marrow with clear pathological evidence: a case report and literature review
por: Wang, Xiankun, et al.
Publicado: (2021)

Serological reactivity of inactivated SARS-CoV-2 vaccine based on an S-RBD neutralizing antibody assay
por: Zhang, Hui, et al.
Publicado: (2022)

High levels of C‐reactive protein‐to‐albumin ratio (CAR) are associated with a poor prognosis in patients with severe fever with thrombocytopenia syndrome in early stage
por: Liu, Zishuai, et al.
Publicado: (2022)

Genomic, immunological, and clinical analysis of COVID‐19 vaccine breakthrough infections in Beijing, China
por: Tian, Di, et al.
Publicado: (2022)

A follow-up study of respiratory and physical function after discharge in patients with redetectable positive SARS-CoV-2 nucleic acid results following recovery from COVID-19
por: Wu, Qian, et al.
Publicado: (2021)

Diltiazem inhibits SARS-CoV-2 cell attachment and internalization and decreases the viral infection in mouse lung
por: Wang, Xinxin, et al.
Publicado: (2022)

Alpha-Soluble NSF Attachment Protein Prevents the Cleavage of the SARS-CoV-2 Spike Protein by Functioning as an Interferon-Upregulated Furin Inhibitor
por: Wang, Jinliang, et al.
Publicado: (2022)

SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells
por: Wang, Jinliang, et al.
Publicado: (2021)

Reactivation of Acute Retinal Necrosis following SARS-CoV-2 Infection
por: Gonzalez, Monica P., et al.
Publicado: (2021)

The predictive effect of the platelet-to-lymphocyte ratio (PLR) and the neutrophil-to-lymphocyte ratio (NLR) on the risk of death in patients with severe fever with thrombocytopenia syndrome (SFTS): a multi-center study in China
por: Wang, Xiankun, et al.
Publicado: (2021)

Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice
por: Wang, Jinliang, et al.
Publicado: (2020)

Author Correction: SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells
por: Wang, Jinliang, et al.
Publicado: (2021)

Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?
por: Bi, Jianping, et al.
Publicado: (2020)

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses
por: Li, Qianqian, et al.
Publicado: (2022)

A REPORT OF FUNGAL EMPYEMA FOLLOWING RECOVERY OF SEVERE SARS-COV-2 INFECTION
por: Glendening, Joseph, et al.
Publicado: (2020)

Characterization of the Human Oropharyngeal Microbiomes in SARS‐CoV‐2 Infection and Recovery Patients
por: Gao, Ming, et al.
Publicado: (2021)

Reinfection and reactivation of SARS-CoV-2
por: Dowran, Razieh, et al.
Publicado: (2022)

Clemastine improves hypomyelination in rats with hypoxic–ischemic brain injury by reducing microglia-derived IL-1β via P38 signaling pathway
por: Xie, Di, et al.
Publicado: (2020)

Predictive Value of Triglyceride-Glucose Index for In-hospital Mortality in Patients With Severe Fever With Thrombocytopenia Syndrome: A Multi-Center Observational Study
por: Zhang, Tingyu, et al.
Publicado: (2022)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
por: Lv, Huibin, et al.
Publicado: (2020)

Reactivated chronic graft-versus-host disease following SARS-CoV-2 infection
por: Florenzo, Brian, et al.
Publicado: (2022)

Incidence determinants and serological correlates of reactive symptoms following SARS-CoV-2 vaccination
por: Holt, Hayley, et al.
Publicado: (2023)

SARS-CoV-2 as an Oncolytic Virus Following Reactivation of the Immune System: A Review
por: Bounassar-Filho, Joao P., et al.
Publicado: (2023)

A ubiquitous bone marrow reservoir of preexisting SARS-CoV-2-reactive memory CD4(+) T lymphocytes in unexposed individuals
por: Li, Jinchan, et al.
Publicado: (2022)

Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19
por: Li, Kening, et al.
Publicado: (2020)

Superspreading of SARS-CoV-2 in the USA
por: Pozderac, Calvin, et al.
Publicado: (2021)

Reactive Arthritis Post-SARS-CoV-2
por: Ouedraogo, Faizal, et al.
Publicado: (2021)

Reactive arthritis with SARS-COV-2 as a trigger()
por: Ruiz-del-Valle, Víctor, et al.
Publicado: (2022)

Eosinophils and basophils in severe fever with thrombocytopenia syndrome patients: Risk factors for predicting the prognosis on admission
por: Liu, Zishuai, et al.
Publicado: (2022)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2
por: Bates, Timothy A., et al.
Publicado: (2021)

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
por: Ou, Xiuyuan, et al.
Publicado: (2020)

Cross-reactivity of SARS-CoV-2– and influenza A–specific T cells in individuals exposed to SARS-CoV-2
por: Chaisawangwong, Worarat, et al.
Publicado: (2022)

Identification of the SARS-unique domain of SARS-CoV-2 as an antiviral target
por: Qin, Bo, et al.
Publicado: (2023)

Comparative therapeutic efficacy of interferon alfa-2b and combination lopinavir/ritonavir plus interferon alfa-2b against SARS-CoV-2
por: Liu, Jingyuan, et al.
Publicado: (2021)

Early Defervescence and SARS Recovery
por: Wang, Jann-Tay, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_isks02s5ih1rf0i8rronc0ra0i